CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer - Related Studies

CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer

This study has been completed.

Study NCT00075192. Last updated on November 8, 2006. Information provided by Pfizer

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Prostatic Neoplasms

2	More general conditions related to this trial
		Genital Diseases, Male
		Genital Neoplasms, Male
		Neoplasms
		Neoplasms by Site
		Prostatic Diseases
		Urogenital Neoplasms

3	Interventions listed in this trial
		leuprolide acetate and bicalutamide

4	Additional drug interventions recognized in this trial
		Bicalutamide
		Leuprolide

5	More general drug interventions related to this trial
		Androgen Antagonists
		Antineoplastic Agents
		Antineoplastic Agents, Hormonal
		Fertility Agents
		Fertility Agents, Female
		Hormone Antagonists
		Hormones, Hormone Substitutes, and Hormone Antagonists
		Pharmacologic Actions
		Physiological Effects of Drugs
		Reproductive Control Agents
		Therapeutic Uses

6	Sponsors listed in this trial
		Pfizer